Hemodynamic effects of human atrial natriuretic peptide after modified fontan procedure

Annals of Thoracic Surgery

Volumn 65, Issue 3, 1998, Pages 761-764

  Hiramatsu, Takeshi ^a   Imai, Yasuharu ^a   Takanashi, Yoshinori ^a   Seo, Kazuhiro ^a   Terada, Masatsugu ^a   Nakazawa, Makoto ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADOLESCENT; ARTICLE; CENTRAL VENOUS PRESSURE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; FONTAN PROCEDURE; HEART HEMODYNAMICS; HUMAN; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADOLESCENT; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CENTRAL VENOUS PRESSURE; CHILD; CHILD, PRESCHOOL; FONTAN PROCEDURE; HEMODYNAMIC PROCESSES; HUMANS; PULMONARY CIRCULATION; RADIOIMMUNOASSAY; URINE; VASCULAR RESISTANCE;

EID: 0032033338     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)01352-0     Document Type: Article

References (12)

1. Mayer JE Jr, Helgason H, Jonas RA, et al. Extending the limits for modified Fontan procedures. J Thorac Cardiovasc Surg. 92:1986;1021-1028.
2. De Bold AJ. Atrial natriuretic factor a hormone produced by the heart . Science. 230:1985;767-770.
3. Sudoh T, Kanagawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature. 332:1988;78-81.
4. Yoshimura M, Yasue H, Tanaka H, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation. 87:1993;464-469.
5. Saito Y, Nakao K, Nishimura K, et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure. Beneficial effects on left ventricular function. Circulation. 76:1987;115-124.
6. Taniyasu N, Koh E, Hiramatsu T. Experiences of Carperitide (synthetic human atrial natriuretic peptide) after cardiovascular surgery. Jpn J Thorac Surg. 49:1996;359-363.
7. Adnot S, Andrivet P, Chabrier PE, et al. Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. J Clin Invest. 83:1989;986-993.
8. Modi N, Midgley JP. Atrial natriuretic peptide. Arch Dis Child. 67:1992;1410-1411.
9. Stewart JM, Gewitz MH, Clark BJ, et al. The role of vasopressin and atrial natriuretic factor in postoperative fluid retention after the Fontan procedure. J Thorac Cardiovasc Surg. 102:1991;821-829.
10. Jonas RA. Advances in surgical care of infants and children with congenital heart disease [Review]. Curr Opin Pediatr. 7:1995;572-579.
11. Kieler-Jensen N, Lundin S, Ricksten SE. Vasodilator therapy after heart transplantation effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside . J Heart Lung Transplant. 14:1995;436-443.
12. Bates ER, Shenker Y, Grekin RJ. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. Circulation. 73:1986;1155-1161.